FibroGen H-1B Visa Sponsorship 2026
Pharma & biotech · H-1B sponsor · FY2017–2026
🏢 San Francisco, CA HQ🌐 fibrogen.com
Does FibroGen sponsor H-1B visas and green cards?
Yes. FibroGen has filed 46 H-1B LCAs and 11 PERM green-card cases with the U.S. Department of Labor between FY2017 and FY2026. In FY2025–2026 FibroGen filed 3 H-1B LCAs at a median base salary of $119,642, about 2% below the national H-1B median of $121,966 for the same period. 1 green-card case was decided in FY2024.
San Francisco, CA accounts for 87% of its H-1B filings.
H-1B pay & filings by year
Median base salary (line) and H-1B filing volume (bars), by fiscal year
Show the numbers behind this chart
| Fiscal year | H-1B LCA filings | Median base salary |
|---|---|---|
| FY2025 | 3 | $120k |
| FY2024 | 8 | $134k |
| FY2023 | 4 | $144k |
| FY2022 | 2 | $163k |
| FY2021 | 11 | $149k |
| FY2020 | 7 | $160k |
| FY2019 | 3 | $123k |
| FY2018 | 5 | $121k |
| FY2017 | 3 | $145k |
H-1B wage floor & filing outcomes
What this employer pays against the DOL legal minimum, how senior the roles are, and how the filings were decided
Roles they file for
- 1China Contracts Manager6$138k
- 2Clinical Trial Manager6$160k
- 3Manager, Statistical Programming4$152k
- 4Manager, Clinical Quality Assurance3$116k
- 5Director, Quality Assurance2$186k
- 6IT Business Systems Analyst2$113k
- 7Senior Manager, Clinical Data Management2$159k
- 8Associate Director, Drug Safety Operations1$175k
Where they hire
Green-card (PERM) pay & filings by year
Median green-card offer (line) and PERM filing volume (bars), by fiscal year †
Show the numbers behind this chart
| Fiscal year | PERM filings | Median base salary |
|---|---|---|
| FY2024 | 1 | $186k |
| FY2023 | 3 | $145k |
| FY2022 | 1 | $251k |
| FY2021 | 1 | $204k |
| FY2020 | 1 | $150k |
| FY2018 | 4 | $116k |
Green-card route and outcomes
Worker backgrounds · FY2017–2024
Where their green-card (PERM) workers studied & came from
Patents
- Granted
- 89
- US patents
- Published, not yet granted
- 142
- applications
- Most recent grant
- June 20, 2023
- Top area
- Preparations for medical33
Pay against the local market
FibroGen’s 10 most-filed occupations and metros, FY2017–FY2025. Its median base salary is 105% of the local BLS median for the same work.
| Occupation | Metro | Filings | FibroGen pay | Local BLS median‡ | vs market |
|---|---|---|---|---|---|
| Natural Sciences Managers | San Francisco, CA | 6 | $165,582 | $209,087 | 79% |
| Managers, All Other | San Francisco, CA | 5 | $132,559 | $183,278 | 72% |
| Statisticians | San Francisco, CA | 5 | $154,762 | $122,310 | 127% |
| Medical Scientists | San Francisco, CA | 4 | $123,316 | $122,938 | 100% |
| Biological Technicians | San Francisco, CA | 3 | $77,275 | $57,110 | 135% |
| Industrial Production Managers | San Francisco, CA | 2 | $185,899 | $137,710 | 135% |
| Medical and Health Services Managers | San Francisco, CA | 2 | $175,173 | $138,890 | 126% |
| Lawyers | San Francisco, CA | 2 | $99,431 | $167,110 | 60% |
| Management Analysts | San Francisco, CA | 2 | $143,520 | $115,345 | 124% |
| Operations Research Analysts | San Francisco, CA | 2 | $113,298 | $107,895 | 105% |
About FibroGen
FibroGen is a pharma & biotech company based in San Francisco, CA. It was founded in 1993. It is listed on Nasdaq as KYNB.
- Name (DOL filings)
- FibroGen, Inc.
- Listed
- Nasdaq: KYNB
- Sponsoring since
- FY2017 or earlier
- Headquarters
- 350 Bay Street, San Francisco, CA 94133
- Industry
- Pharma & biotech
- Employees (US, est)
- 54 (2024)
- Revenue FY2025
- $6M -78% from $30M
- Net income FY2025
- $183M +486% from $-48M
- R&D FY2025
- $24M (365% of revenue)
FibroGen pays a median H-1B base of $144,281 across FY2017–2026, about 35% above the typical Pharma & biotech sponsor.
H-1B sponsors similar to FibroGen
| Employer | Filings, all years | Recent filings | Median base | New employment | Level III-IV roles |
|---|---|---|---|---|---|
| Purdue Pharma | 63 | 4 | $183k | 0 | — |
| Spark Therapeutics | 63 | 9 | $103k | 5 | — |
| Denali Therapeutics | 61 | 18 | $148k | 5 | — |
| FibroGen | 46 | 3 | $120k | 1 | — |
| Zydus | 46 | 10 | $131k | 1 | — |
| Agenus | 46 | 6 | $143k | 1 | — |
| Genista Biosciences | 46 | 33 | $82k | 31 | 36% |
